Survey on Physical Activity and Qualify of Life in Fibromuscular Dysplasia

Part of paid clinical trials in Nashville, Tennessee.

Sponsor
Vanderbilt University Medical Center
Study ID
NCT07529691
Status
Recruiting
Apply to this trial

Conditions

  • Fibromuscular Dysplasia
  • Fibromuscular Dysplasia of Arteries
  • Spontaneous Coronary Artery Dissection

Eligibility Criteria

Sex
ALL
Age
18 Years - 100 Years
Healthy Volunteers
Not accepted

Study Details

Fibromuscular dysplasia (FMD) is a disease of the arteries that is not due to plaque build-up or inflammation. While some patients with FMD are health, some may experience heart attacks, strokes, aneurysms or blood vessel dissection/tearing which can be life-threatening. It predominantly impacts women and younger patients. As a result of this diagnosis, many patients are counseled to restrict or avoid certain physical activities out of concern for provoking or worsening vascular complications. There are no guidelines or consensus recommendations regarding appropriate physical activity for patients with FMD. The lack of consensus may lead to confusion for patients and may negatively impact their quality of life. This study will conduct a large, national survey of patients with FMD to assess the type of physical activity restrictions and impact on quality of life and emotional well-being.

Key Dates

Start date
Apr 14, 2026
Status verified
Apr 2026
Primary completion
Apr 30, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
2,000 participants (estimated)

Arms

  • Arm: Patients with fibromuscular dysplasia
    Patients who identify as having a confirmed diagnosis of fibromuscular dysplasia, or patients at Vanderbilt University Medical Center who have a confirmed diagnosis of fibromuscular dysplasia as determined by their provider.

Primary Outcome Measure

Clinician-Recommended Physical Activity Restrictions [ Time Frame: Baseline ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Vanderbilt University Medical CenterNashvilleTennessee37232
Amanda M Morrison, MD
[email protected]
(615) 322-5000
[email protected]
Amanda M Morrison, MD (PRINCIPAL_INVESTIGATOR)
Aaron W Aday, MD, MSc (SUB_INVESTIGATOR)

Find similar trials in Nashville, TN

By research site
Vanderbilt University Medical Center· Nashville, TN

Related Studies